1.03

0.96% -0.01

After Hours: 1.02 -0.01 -0.97%

Organovo Holdings Inc (ONVO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Organovo Holdings Inc stock is currently priced at $1.03, with a 24-hour trading volume of 47,156. It has seen a -0.96% decreased in the last 24 hours and a -8.04% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $1.03 pivot point. If it approaches the $1.01 support level, significant changes may occur.

Previous Close:

$1.04

Open:

$1.02

24h Volume:

47,156

Market Cap:

$11.77M

Revenue:

Net Income/Loss:

$-19.09M

P/E Ratio:

-0.50

EPS:

-2.06

Net Cash Flow:

$-16.92M

1W Performance:

+11.47%

1M Performance:

-8.04%

6M Performance:

-25.90%

1Y Performance:

-41.48%

1D Range:

$1.02

$1.05

52W Range:

$0.85

$2.05

Organovo Holdings Inc Stock (ONVO) Company Profile

Name

Organovo Holdings Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

858 224 1000

Address

11555 Sorrento Valley Road, Suite 100, Solana Beach, CA

Employee

Twitter

@Organovo

Next Earnings Date

2024-02-08

Latest SEC Filings

ONVO's Discussions on Twitter

Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-18	Initiated	H.C. Wainwright	Buy
Nov-10-17	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-25-17	Initiated	Raymond James	Outperform
Aug-11-15	Downgrade	Cantor Fitzgerald	Buy → Hold
Jun-29-15	Initiated	Jefferies	Buy
Jun-29-15	Initiated	Piper Jaffray	Overweight

View All

Organovo Holdings Inc Stock (ONVO) Latest News

Here's Why Organovo Holdings Stock Fell as Much as 28.4% Today - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Here's Why Organovo Holdings Stock Fell as Much as 28.4% Today - Yahoo Lifestyle UK

Yahoo Lifestyle UK

H.C. Wainwright initates Organovo Holdings Inc (ONVO) rating to a Buy – Knox Daily - Knox Daily

Knox Daily

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) - Investing.com India

Investing.com India

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

GlobeNewswire Inc.

Here's Why Organovo Holdings Stock Fell as Much as 28.4% Today - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Organovo Holdings Inc Stock (ONVO) Financials Data

Organovo Holdings Inc (ONVO) Net Income 2024

ONVO net income (TTM) was -$19.09 million for the quarter ending December 31, 2023, a -62.97% decrease year-over-year.

Organovo Holdings Inc (ONVO) Cash Flow 2024

ONVO recorded a free cash flow (TTM) of -$16.92 million for the quarter ending December 31, 2023, a -78.04% decrease year-over-year.

Organovo Holdings Inc (ONVO) Earnings per Share 2024

ONVO earnings per share (TTM) was -$2.17 for the quarter ending December 31, 2023, a -61.94% decline year-over-year.

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.